Cathie Wood Takeda Pharmaceutical CO LTD Transaction History

Ark Investment Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 19, 2022	SELL	$13.54 - $15.35 $106 Million - $121 Million	-7,862,379 Closed	0 $0
Q4 2021 Jan 28, 2022	SELL	$13.17 - $16.4 $74.3 Million - $92.5 Million	-5,639,271 Reduced 41.77%	7,862,379 $107 Million
Q3 2021 Nov 12, 2021	SELL	$16.3 - $17.26 $32.5 Million - $34.4 Million	-1,991,347 Reduced 12.85%	13,501,650 $221 Million
Q2 2021 Aug 05, 2021	SELL	$16.55 - $18.64 $53.4 Million - $60.1 Million	-3,224,147 Reduced 17.23%	15,492,997 $261 Million
Q1 2021 May 13, 2021	BUY	$16.71 - $19.9 $169 Million - $201 Million	10,098,979 Added 117.18%	18,717,144 $342 Million
Q4 2020 Feb 12, 2021	BUY	$15.39 - $18.97 $115 Million - $142 Million	7,461,868 Added 645.32%	8,618,165 $157 Million
Q3 2020 Oct 30, 2020	BUY	$17.1 - $19.19 $19.8 Million - $22.2 Million	1,156,297 New	1,156,297 $20.6 Million

320

70.4M

939K

233K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $43.1B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Ark Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Ark Investment Management LLC and Cathie Wood with notifications on news.